06/01/2017 | Bradley Straatsma
Bradley Straatsma, Founding Director of the Jules Stein Eye Institute, UCLA.
05/31/2017 | Stephen Lane
How we’re overcoming the challenges of effectively delivering topical eye medication
05/31/2017 | Günther Grabner
Solutions of the corneal plane are the best for younger patients with presbyopia.
05/31/2017 | Nader Bayoumi
The instinct is to act early to save vision – but at what cost?
05/31/2017 | Ruth Steer, Ruth Steer
Characteristic retinal lesions provide clues on how Ebola virus enters the eye.
05/31/2017 | Mark Hillen
Can an anti-VEGF agent outdo PRP for the treatment of PDR?
05/31/2017 | Ruth Steer
In patients with glaucoma or thin corneas look to the difference between DCT and GAT.
Amblyopes might soon be able to ditch the patch for virtual reality therapy.
Collaborations, acquisitions and a potential case of misleading information…
Topical anti-VEGF therapy may offer AMD patients an alternative to injections.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: